Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
EHC 2022
Programm
Poster
Personen
Suche
DE
Alle Personen
Robert Croop
Sortiert nach Datum
Typ
Einsätze
09.12.2022
15:40
–
15:45
3 Min.
2 Min.
ePoster
P104
A Phase 2/3 Open-label, Long-term, Safety Trial of Zavegepant 10 mg Nasal Spray for the Acute Treatment of Migraine
CGRP inhibitors in the clinic, Migraine
16:40
–
16:45
3 Min.
2 Min.
ePoster
P149
Safety and Tolerability of Rimegepant Every Other Day for Preventive Treatment of Migraine Plus As-Needed for Acute Treatment of Migraine: Results from A 52-Week, Open-Label Extension Study
CGRP inhibitors in the clinic, Migraine
16:50
–
16:55
3 Min.
2 Min.
ePoster
P136a
Efficacy and Safety of Zavegepant Nasal Spray for the Acute Treatment of Migraine: Results of a Phase 3 Double-Blind, Randomized, Placebo Controlled Trial
CGRP inhibitors in the clinic, Migraine
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz